chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on lowerlimbs began at day two.No likage was made with injection. On day five rash was disseminated across  torso and limbs. Rash resided. Malaise continues to day 7.Day 7 mid day fever reaches 102. Next three days peraks near 104 despite TYenol then Advil every 4 fours across all 24. Faint unprodcutive cough commences at day 9. Productive cough commences on day 12. Fever reduces to 102 on day 12 and is still present (peaks at 101 each day). at day 15 post injection. Neever any muscle pain or aches GI symptoms except some anorexia from days 7-11.
Started with Hives and rash at first localized to limbs that has persisted to this day. by end of month was having fatigue and joint pain. Symptoms have increased over the last year. received a Lupus diagnosis with phospholipid disorder in August. Now have inflammation increased fatigue, Rash has spread to include all locations in the last year, legs, arms, torso, and head. Joint pain continues at incressed rate.  have periodic high blood pressure and regular fever.
1235 notified safety officer and Site that client possibly recieved a 3rd dose today according to VIIS. Client sitting in observation post vaccination. Record in VIIS showed that patient's first dose on 5/18/2021  and  7/19/2021. Patient unable to recall first dose.Asked "when and where was your first dose?" Client replied "2 years ago. 2 weeks ago. It was here." Possible memory problems, unable to remember dates or details. Denies having gone prior to today, "I never been there." Address and contact info confirmed with patient and record from VIIS. Patient told to follow up with PCP, reoriented that he does not need any further COVID-19 vaccinations unless told otherwise by PCP.
RED AND FLESH TONE RASH ON FACE AND BODY. SKIN HAS NOT CLEARED SINCE. ADVISED NOT TO WASH W/CLOTH AND SOAP.
This case was reported by a consumer via call center representative and described the occurrence of nausea in a 71-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included SHINGRIX. On 19th September 2018, the patient received the 2nd dose of SHINGRIX. On 19th September 2018, less than a day after receiving SHINGRIX, the patient experienced nausea (serious criteria hospitalization), vomiting (serious criteria hospitalization), dehydration (serious criteria hospitalization), injected limb mobility decreased (serious criteria hospitalization), headache (serious criteria hospitalization) and fever (serious criteria hospitalization). On an unknown date, the outcome of the nausea, vomiting, dehydration, injected limb mobility decreased, headache and fever were recovered/resolved. It was unknown if the reporter considered the nausea, vomiting, dehydration, injected limb mobility decreased, headache and fever to be related to SHINGRIX. Additional details were provided as follows: On 3rd July 2018 at 4:33 pm, the patient received the 1st dose of SHINGRIX and did not experience side effects. The patient received 2nd dose of SHINGRIX in the left deltoid and she could not lift her left arm that took about a week for this to resolve. Around 11:30 pm, the patient began to feel nauseous. She threw up all night and had a massive headache which involved the temples, eyes, and nose. She had a fever of 100.3. The patient went to the hospital on 20th September 2018 and stayed overnight. The patient was released about 2 pm on Friday 21st September 2018.  The patient was dehydrated from throwing up and the headache while in the hospital and they did a CAT scan to rule out a stroke. All reported events had resolved. The patient had provided contact details of her physician.
8 days after Proquad and Hep A vaccines received, developed fever to 102.4 tympanic.
Painful swollen lymph nodes along left clavicle noticed 2/4/21 at 6pm still present and painful. Swollen lids under eyes (mild) noted on 2/6/21 have now subsided after 2 hours.
Information has been received from a physician concerning an 72 year old female who in approximately Sept 2004, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 647654/0865N). Post vaccination, the patient developed an injection site reaction which included upper arm swelling and redness that persisted for 5 days. Unspecified medical attention was sought. the patient was given unspecified antibiotics to treat an infection in case it is not just a local reaction. The patients outcome was not reported. The reporter stated that he would like an investigation into the lot to see if other problems were reported. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. It was also reported that a male patient (WAES0410USA01073) and another female patient WAES0410USA01074) developed injection site reactions after vaccination with pneumococcal 23v polysaccharide vaccine from the same lot. Additional information has been requested.
Conjunctivitis, cough, edema face, edema tongue, rhinitis. This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 248517).  A 52 year old female patient with no known allergies had received a first dose intramuscular injection of FLUZONE SV 2005-2006, lot number U1870AA on 16 November 2005 at 09:15 a.m., and by 13:00 pm the patient developed cough so she ate ice. Three hours later, she experienced burning, red and puffy eyes, her nasal airway was swollen- "no air" (coded by VAERS as rhinitis) and the back of her tongue was swollen. Corrective treatments included BENADRYL 25 mg x three and the patient went to sleep. The patient also experienced face edema which was included in the coding from VAERS database; however this was not mentioned in the narrative. The next day, the patient was reported to have been "okay" and recovered from the event.
This spontaneous report as received from a nurse refers to a newborn patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patient missed a does of RECOMBIVAX HB lot # J007946, expiration date 24-MAR-2016 and lot J012567 expiration date 30-JAN-2016, because the medication appeared gray and cloudy. Vaccination was rescheduled for the next day. No adverse event was reported. PQC involved. This is one of several reports form the same source. Additional information has been requested.
Syncopal episode. No loss of consciousness. Lasted about a minute per mom. No additional symptoms.
Missed mentrual cycle - my cycle is normal every month 28-30 days long. My cycle was 67 days following the vaccine. I then Am experiencing heavy bleeding and clotting. I am Bleeding through súper plus tampons and pads while wearing them simultaneously for 2 hours. I  wake up in blood. The bleeding is unlike anything I?ve ever experienced
Erythema, tenderness and slight swelling at injection area which started later on the same day vaccine was received.  Pt came in to the walk-in clinic 6/13/19. Localized erythema 9 cm in diameter centered at deltoid area. Very mild swelling, slight tenderness to palpation. No warmth, fluctuance or drainage.
Expired vaccine doses administered 3 patients/3 booster doses administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine doses administered 3 patients/3 booster doses administered after manufacturer date of expiry) in a 25-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K212A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine doses administered 3 patients/3 booster doses administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine doses administered 3 patients/3 booster doses administered after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information were given.  Reporter stated that on 24-May-2022, 1 vial was placed in the refrigerator from which 1 dose (0.25 mL booster dose) was given. No temperature excursions were reported.  No treatment information were given.   This case was linked to MOD-2022-589616 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2022: Follow up contains significant information: Patient demographics (age) added.
Patient had right leg swelling and erythema with reports of itching and pain. Significant circumferential swelling but no signs of taut skin or signs of compartment syndrome. Patient with fever as well. Developed over the last 10 hours prior to presentation in the ED. Patient's mother had been called today as well and told that one of the vaccines of the 3 he received (polio, MMRV, and DTAP) was expired, but she wasn't told which one.
It gave flu to patient; Initial information received on 06-Oct-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health care professional.   This case involves adult and unknown gender patient who it was reported it gave me flu (influenza) while receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease, or risk factor. The patient medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via an unknown route in unknown administration site for Prophylactic vaccination.  On an unknown date, the patient developed a non-serious event it gave flu to patient (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "last flu shot I got two years ago, gave me the flu, so will never take another one. If I go out I wear a mask anyway. I'm tired of being told what to do".  There were no lab data/results available.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received ant corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
POSSIBLE POOR QUALITY VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 24-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced possible poor quality vaccine administered. The action taken with covid-19 vaccine was not applicable. The outcome of possible poor quality vaccine administered was not reported. This report was non-serious. This report was associated with product quality complaint: 90000180575. The suspected product quality complaint has been confirmed to be voided (did not meet PQC criteria) based on the PQC evaluation/investigation performed
A report was received from a health professional on 16Oct02, concerning about 20 vaccines between the ages of 6-35 months who were inadvertently administered Fluvirin between 14-16Oct02. Between 14-16Oct02, about 20 vaccinees between the ages of 6-35 months were inadvertently administered 0.25ml of the Fluvirin vaccine in the vastus lateralis. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update 1 27Dec02: A report received from a health care professional indicated that a 14 month old male vaccinee inadvertently received Fluvirin vaccination on 16Oct02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
pt recv vax & 10 days later exp a generalized macular papular rash on palms & soles; rash resolved over 3 to 5 days, & pt recovered;
Patient describes symptoms of headache, nausea, feeling light headed and faint. States she has fallen down once from feeling light headed. States the symptoms started on the night the vaccines were given. Encouraged patient to see personal care provider and that we would see her back in clinic. She states she will see her private provider.
My first vaccine shot 1/21/21. My arm was very sore for 3 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Jan2021 15:15 (Lot number: EL9263) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "sjogrens syndrome" (unspecified if ongoing); "hypo thyroid" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID, start date: 2021. Past drug history included: Sulfa, reaction(s): "allergy: sulfa", notes: sulfa,; Augmentin, reaction(s): "allergic: augmentin/penicillin allergy", notes: Reported as penciling/Augmentin allergy. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 21Jan2021, outcome "unknown", described as "My first vaccine shot 1/21/21. My arm was very sore for 3 days.". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Patient states her blood pressure 110/70 whole life. Her first vaccine shot received on 21jan2021 and her arm was very sore for 3 days. On 18Feb2021, she administered her second Covid-19 shot.The day after that shot she had fever, chills and soreness. Suddenly on July 25  she began vomiting which lasted into that night. For the next 5 days she remained very dizzy. By Sun. July 31, she checked herself into a hospital and her blood pressure was 207/94. She was given medication for BP, but it is still very erratic.  No follow-up attempts are possible. No further information is expected.  Follow-up#01 (19Aug2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101023581 same patient/reporter, different vaccine dose/AE
I woke up Monday 10/25/21 completely blind in my left eye. No pain. Just complete vision loss. Over the course of the morning some vision returned and at this point, 10/29/21 only the upper right had quadrant is still experiencing vision loss
5/11/05: Severe pain both legs, beginning about 7 hrs after vaccination. Pt is a runner. 5/12/05:Temp up to 102.5, chills, sweats, aches, severe leg pain, sore throat. Went to ER on 5/12/05. Treated for pain and fever and discharged. Was sick for about one week.
lymph glands in my left arm pit are very enlarged and very painful to touch; lymph glands in my left arm pit are very enlarged and very painful to touch.; running a fever of 100.1 to 101 for the past three days; extreme body aches/ left area is terribly sore; chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Jan2022 13:45 (Lot number: FD7218) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Ulcerative colitis" (unspecified if ongoing); "HTN" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; SULFASALAZINE. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 04Jan2022 21:30, outcome "unknown", described as "lymph glands in my left arm pit are very enlarged and very painful to touch"; LYMPH NODE PAIN (non-serious) with onset 04Jan2022 21:30, outcome "unknown", described as "lymph glands in my left arm pit are very enlarged and very painful to touch."; PYREXIA (non-serious) with onset 04Jan2022 21:30, outcome "unknown", described as "running a fever of 100.1 to 101 for the past three days"; PAIN (non-serious) with onset 04Jan2022 21:30, outcome "unknown", described as "extreme body aches/ left area is terribly sore"; CHILLS (non-serious) with onset 04Jan2022 21:30, outcome "unknown", described as "chills". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain, pyrexia, pain, chills.  Additional Information: No other vaccine was taken in four weeks. No covid prior vaccination. No covid tested post vaccination. Patient's left area was terribly sore but what was most concerning was that the lymph glands in her left arm pit were very enlarged and very painful to touch. She had been running a fever of 100.1 to 101 for the past three days. She had extreme body aches and chills.  Follow-up attempts are completed. No further information is expected.
Information has been received from a female concerning her 79 year old mother with weakened immune system, diabetes and osteoporosis and a history of cancer 4 times and no history of drug reactions or allergies who in January or February 2008 was vaccinated with ZOSTAVAX (Oka/Merck) 0.65ml subcutaneously.  Concomitant therapy included "a lot of medications", diabetes medicines and ARIMIDEX.  "A couple weeks after the vaccination", the patient was unable to move her arms and shoulders because they "hurt very badly".  She went to her rheumatologist who said that it was a pinched nerve.  She later went to a neurologist who told her it was a "nerve virus" and an orthopedist confirmed this diagnosis.  Due to this adverse event, the patient fell in the shower and developed arthritis in both hands because she tried to break her fall with her hands.  The patient's nerve virus infection persisted.  The outcome of arthritis was not reported.  No further information is available.
diagnosed with covid 19; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 22Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got on 22Jan2021 the first dose of the vaccine and she was scheduled to get the second on 12Feb2021 but she got diagnosed with Covid 19 on 2021. She would like to know if she should receive the second dose.  Outcome of the event was unknown.  Information about batch/lot number has been requested.
30 people were administered the vaccines for past 24hours (stored in between  8° to 25°C); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (30 people were administered the vaccines for past 24hours (stored in between  8° to 25°C)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced PRODUCT STORAGE ERROR (30 people were administered the vaccines for past 24hours (stored in between  8° to 25°C)). On 27-May-2021, PRODUCT STORAGE ERROR (30 people were administered the vaccines for past 24hours (stored in between  8° to 25°C)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter. No treatment information were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Followup received included no new significant information. The reported confirmed no adverse events were reported.
Headache, Myalgia, Arthralgia, CHILLS, FATIGUE, FOGGY HEAD Narrative:
Three days after my second shot (on 05/03/2021) I started to feel pain in my left arm, tightness in chest, and I became very light headed.  I tried to go to shower but I could not walk and laid down.  My ears felt very tingly and I thought I was going to pass out but as far as I know, I did not.    I went to my primary care doctor and he has me taking baby aspirin daily (in case blood clot) and wanted to see if it got better I am going to follow up with a cardiologist.  I've never had a problem with heart before and get an annual physical at work.
Flu-like symptoms, very sore right arm socket, ringing in both ears, rapid heart beat, arm hot at shot location - small lump. Occurred 10 hours post vax.  Follow up 06/05/2000: "Patient partially recovered from adverse event.  4 weeks after shot-still have sore joints in shoulder and neck getting better.  Restless nights sleeping because of pain.  Fatigue all day.  Patient received further shots since reported event.  Events were more flu like symptoms but no sore shoulder in other arm-fatigue feeling."
Patient was vaccinated 3/26.  She noticed her injection site was sore and warm on 3/27.  She happened to come in today and the injection site was red, swollen (raised) and warm to the touch.  The area was apporoximately 2X3 inches.  Referred patient to her MD for further f/u if needed.  No other s/s reported.
sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) outcome was unknown.            No concomitant medications were reported. No treatment details were reported.; Sender's Comments: Although a temporal association cannot be established, based on the information provided, a causal association cannot be excluded.
8 hours after receiving the first dose I experienced body aches, chills, fever, lack of appetite, fatigue. These symptoms went on for 24 hours before I started feeling better. 3 weeks later, received the 2nd dose and experienced the same side effects for 24 hours before feeling better. However, after second 2nd I?ve been experiencing vertigo-like dizziness occurring episodically. I?ve never experienced this type of dizziness and I am a certain the vaccine caused it.
Pt was vaccinated in 1997. Subsequently, the pt was seen in occupational health clinic for preplacement physical and a titer was drawn which indicated a negative antibody to mumps. The pt reported that she had all childhood vaccines.
Fever 100.5 degree F-101. Achy joints the next day (knees, hips, shoulders).